CRISPR Therapeutics (Brazil) Probability of Future Stock Price Finishing Over 31.52
| C2RS34 Stock | 31.52 1.89 6.38% |
CRISPR |
CRISPR Therapeutics Target Price Odds to finish over 31.52
The tendency of CRISPR Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 31.52 | 90 days | 31.52 | about 85.76 |
Based on a normal probability distribution, the odds of CRISPR Therapeutics to move above the current price in 90 days from now is about 85.76 (This CRISPR Therapeutics AG probability density function shows the probability of CRISPR Stock to fall within a particular range of prices over 90 days) .
Assuming the 90 days trading horizon CRISPR Therapeutics has a beta of 0.2 suggesting as returns on the market go up, CRISPR Therapeutics average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding CRISPR Therapeutics AG will be expected to be much smaller as well. Additionally CRISPR Therapeutics AG has an alpha of 0.0087, implying that it can generate a 0.008657 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). CRISPR Therapeutics Price Density |
| Price |
Predictive Modules for CRISPR Therapeutics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as CRISPR Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Please note, it is not enough to conduct a financial or market analysis of a single entity such as CRISPR Therapeutics. Your research has to be compared to or analyzed against CRISPR Therapeutics' peers to derive any actionable benefits. When done correctly, CRISPR Therapeutics' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in CRISPR Therapeutics.CRISPR Therapeutics Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. CRISPR Therapeutics is not an exception. The market had few large corrections towards the CRISPR Therapeutics' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold CRISPR Therapeutics AG, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of CRISPR Therapeutics within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.01 | |
β | Beta against Dow Jones | 0.20 | |
σ | Overall volatility | 2.45 | |
Ir | Information ratio | -0.0004 |
CRISPR Therapeutics Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of CRISPR Therapeutics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for CRISPR Therapeutics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| CRISPR Therapeutics had very high historical volatility over the last 90 days |
CRISPR Therapeutics Technical Analysis
CRISPR Therapeutics' future price can be derived by breaking down and analyzing its technical indicators over time. CRISPR Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of CRISPR Therapeutics AG. In general, you should focus on analyzing CRISPR Stock price patterns and their correlations with different microeconomic environments and drivers.
CRISPR Therapeutics Predictive Forecast Models
CRISPR Therapeutics' time-series forecasting models is one of many CRISPR Therapeutics' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary CRISPR Therapeutics' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about CRISPR Therapeutics
Checking the ongoing alerts about CRISPR Therapeutics for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for CRISPR Therapeutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| CRISPR Therapeutics had very high historical volatility over the last 90 days |